1 | morbidity | 17,685 |
2 | morbidity/mortality | 79 |
3 | myonecrosis | 64 |
4 | mortality/morbidity | 27 |
5 | morbi-mortality | 26 |
6 | morbimortality | 21 |
7 | morbility | 16 |
8 | perstans | 10 |
9 | t2- | 8 |
10 | 6.0- | 5 |
11 | glycogenesis | 5 |
12 | hypodermal | 5 |
13 | obesity- | 5 |
14 | toxicodynamics | 5 |
15 | 1.86- | 4 |
16 | caapi | 4 |
17 | caspase‑9 | 4 |
18 | chemotoxicity | 4 |
19 | crouching | 4 |
20 | ketonemia | 4 |
21 | kj∕mol | 4 |
22 | sights | 4 |
23 | snrnas | 4 |
24 | 3-methylcrotonylglycine | 3 |
25 | 60ng/ml | 3 |
26 | agresti | 3 |
27 | apoa- | 3 |
28 | brd7 | 3 |
29 | ciifn-i | 3 |
30 | creaminess | 3 |
31 | dumfries | 3 |
32 | geno- | 3 |
33 | ghrita | 3 |
34 | hirsuta | 3 |
35 | idl- | 3 |
36 | imageability | 3 |
37 | lactiacidemia | 3 |
38 | neurosonography | 3 |
39 | photosynthesis- | 3 |
40 | rs10741657 | 3 |
41 | sexology | 3 |
42 | tcf-1 | 3 |
43 | uapo2 | 3 |
44 | vasculo- | 3 |
45 | wind-dampness | 3 |
46 | 1.0-1.2mg/kg | 2 |
47 | 1050°c | 2 |
48 | 18:1t-11 | 2 |
49 | alkylidenemalononitriles | 2 |
50 | aminaftone | 2 |
51 | amph-cpp | 2 |
52 | baro/volutrauma | 2 |
53 | bias/mse | 2 |
54 | binols | 2 |
55 | bio-piracy | 2 |
56 | body-focus | 2 |
57 | bubr1 | 2 |
58 | caryophyllideans | 2 |
59 | chamber-level | 2 |
60 | coproporphyrins | 2 |
61 | cspcs | 2 |
62 | desulfomicrobium | 2 |
63 | development- | 2 |
64 | digitalemia | 2 |
65 | dyrk | 2 |
66 | e-apts | 2 |
67 | efflorescence | 2 |
68 | epiclitum | 2 |
69 | epileptogenicity | 2 |
70 | event-rates | 2 |
71 | firepower | 2 |
72 | gonoccocal | 2 |
73 | graft- | 2 |
74 | hashsp70 | 2 |
75 | hiv-exposure | 2 |
76 | hyper-cholesterolaemia | 2 |
77 | hypervolemia/hemodilution | 2 |
78 | hypogalactia | 2 |
79 | hypoxia- | 2 |
80 | insulinomimetic | 2 |
81 | leo/ml | 2 |
82 | leukopoiesis | 2 |
83 | methionol | 2 |
84 | mir-142-5p | 2 |
85 | mir-365 | 2 |
86 | mir-371-5p | 2 |
87 | motorneurons | 2 |
88 | mv-uv | 2 |
89 | osteo-integration | 2 |
90 | p-xylylenediamine | 2 |
91 | p2- | 2 |
92 | photophobia/phonophobia | 2 |
93 | piperidine-3,4-diol | 2 |
94 | pnpcdefg | 2 |
95 | predacity | 2 |
96 | red-meat | 2 |
97 | reestenosis | 2 |
98 | respiratory- | 2 |
99 | rosoxacin | 2 |
100 | rs6773957 | 2 |
101 | securin | 2 |
102 | solace | 2 |
103 | ssti-related | 2 |
104 | staix-1 | 2 |
105 | tetherin | 2 |
106 | tg/ldl | 2 |
107 | underdiagnosing | 2 |
108 | underscreening | 2 |
109 | venonemia | 2 |
110 | wind-dampness-dispelling | 2 |
111 | yi-qi-jian-pi | 2 |
112 | δ-ala | 2 |
113 | δrk | 2 |
114 | 1.3-2.7- | 1 |
115 | 1.82- | 1 |
116 | 1.97- | 1 |
117 | 14:1c-9 | 1 |
118 | 1h-3-benzazonine | 1 |
119 | 2aa- | 1 |
120 | 3-methyhistidine | 1 |
121 | 3.40- | 1 |
122 | 37- | 1 |
123 | ag2s2o7 | 1 |
124 | alcohol-hangover | 1 |
125 | ampa- | 1 |
126 | anti-rotavirus- | 1 |
127 | antiohyperglycemic | 1 |
128 | arterial-alveolar-difference | 1 |
129 | bradyasystole | 1 |
130 | cd68-immunoreactivity | 1 |
131 | cinobufacin- | 1 |
132 | complications.bladder | 1 |
133 | complications.deferoxamine | 1 |
134 | complications/sepsis | 1 |
135 | contraction- | 1 |
136 | cost/punishment | 1 |
137 | dendricity | 1 |
138 | depression-research | 1 |
139 | diarrhoe | 1 |
140 | diseasea | 1 |
141 | diseases/injuries | 1 |
142 | dose-per-pulse | 1 |
143 | energy-intake | 1 |
144 | events-stroke | 1 |
145 | flna-g288r | 1 |
146 | fracture-rate | 1 |
147 | g-tolerance | 1 |
148 | glt1-reporter | 1 |
149 | gynaecopathia | 1 |
150 | haemogblobin | 1 |
151 | hdl-cholersterol | 1 |
152 | health/prematurity | 1 |
153 | hole-only | 1 |
154 | hormone-withdrawal | 1 |
155 | hypoparathyroidy | 1 |
156 | hysteroscops | 1 |
157 | h₂o₂production | 1 |
158 | ikds | 1 |
159 | il-1- | 1 |
160 | interleukins-1α | 1 |
161 | iso-valerate | 1 |
162 | local/vascular | 1 |
163 | low-density- | 1 |
164 | lrh-1 | 1 |
165 | mater-nal | 1 |
166 | nbt-reduction | 1 |
167 | other-derogation | 1 |
168 | pain-level | 1 |
169 | patch×time | 1 |
170 | paturition | 1 |
171 | pbsc- | 1 |
172 | pg-fluctuations | 1 |
173 | phospho-jnk1/2 | 1 |
174 | potentiation- | 1 |
175 | pyruria | 1 |
176 | quimioprophylaxis | 1 |
177 | renocortical | 1 |
178 | rfs/pfs | 1 |
179 | stress-fetal | 1 |
180 | stroke/mi | 1 |
181 | tooth-aches | 1 |
182 | total-igf-i | 1 |
183 | total-ldl | 1 |
184 | tramadol-sparing | 1 |
185 | vasoplasm | 1 |
186 | ventral/limbic | 1 |
187 | videostrobolaryngoscopy | 1 |
188 | visits/appointments | 1 |
189 | vlh | 1 |
190 | whvpg | 1 |
191 | β-glucoronidase | 1 |
192 | ∼1.6- | 1 |
1 | 1.0-1.2mg/kg | 2 |
2 | 1.3-2.7- | 1 |
3 | 1.82- | 1 |
4 | 1.86- | 4 |
5 | 1.97- | 1 |
6 | 1050°c | 2 |
7 | 14:1c-9 | 1 |
8 | 18:1t-11 | 2 |
9 | 1h-3-benzazonine | 1 |
10 | 2aa- | 1 |
11 | 3-methyhistidine | 1 |
12 | 3-methylcrotonylglycine | 3 |
13 | 3.40- | 1 |
14 | 37- | 1 |
15 | 6.0- | 5 |
16 | 60ng/ml | 3 |
17 | ag2s2o7 | 1 |
18 | agresti | 3 |
19 | alcohol-hangover | 1 |
20 | alkylidenemalononitriles | 2 |
21 | aminaftone | 2 |
22 | ampa- | 1 |
23 | amph-cpp | 2 |
24 | anti-rotavirus- | 1 |
25 | antiohyperglycemic | 1 |
26 | apoa- | 3 |
27 | arterial-alveolar-difference | 1 |
28 | baro/volutrauma | 2 |
29 | bias/mse | 2 |
30 | binols | 2 |
31 | bio-piracy | 2 |
32 | body-focus | 2 |
33 | bradyasystole | 1 |
34 | brd7 | 3 |
35 | bubr1 | 2 |
36 | caapi | 4 |
37 | caryophyllideans | 2 |
38 | caspase‑9 | 4 |
39 | cd68-immunoreactivity | 1 |
40 | chamber-level | 2 |
41 | chemotoxicity | 4 |
42 | ciifn-i | 3 |
43 | cinobufacin- | 1 |
44 | complications.bladder | 1 |
45 | complications.deferoxamine | 1 |
46 | complications/sepsis | 1 |
47 | contraction- | 1 |
48 | coproporphyrins | 2 |
49 | cost/punishment | 1 |
50 | creaminess | 3 |
51 | crouching | 4 |
52 | cspcs | 2 |
53 | dendricity | 1 |
54 | depression-research | 1 |
55 | desulfomicrobium | 2 |
56 | development- | 2 |
57 | diarrhoe | 1 |
58 | digitalemia | 2 |
59 | diseasea | 1 |
60 | diseases/injuries | 1 |
61 | dose-per-pulse | 1 |
62 | dumfries | 3 |
63 | dyrk | 2 |
64 | e-apts | 2 |
65 | efflorescence | 2 |
66 | energy-intake | 1 |
67 | epiclitum | 2 |
68 | epileptogenicity | 2 |
69 | event-rates | 2 |
70 | events-stroke | 1 |
71 | firepower | 2 |
72 | flna-g288r | 1 |
73 | fracture-rate | 1 |
74 | g-tolerance | 1 |
75 | geno- | 3 |
76 | ghrita | 3 |
77 | glt1-reporter | 1 |
78 | glycogenesis | 5 |
79 | gonoccocal | 2 |
80 | graft- | 2 |
81 | gynaecopathia | 1 |
82 | haemogblobin | 1 |
83 | hashsp70 | 2 |
84 | hdl-cholersterol | 1 |
85 | health/prematurity | 1 |
86 | hirsuta | 3 |
87 | hiv-exposure | 2 |
88 | hole-only | 1 |
89 | hormone-withdrawal | 1 |
90 | hyper-cholesterolaemia | 2 |
91 | hypervolemia/hemodilution | 2 |
92 | hypodermal | 5 |
93 | hypogalactia | 2 |
94 | hypoparathyroidy | 1 |
95 | hypoxia- | 2 |
96 | hysteroscops | 1 |
97 | h₂o₂production | 1 |
98 | idl- | 3 |
99 | ikds | 1 |
100 | il-1- | 1 |
101 | imageability | 3 |
102 | insulinomimetic | 2 |
103 | interleukins-1α | 1 |
104 | iso-valerate | 1 |
105 | ketonemia | 4 |
106 | kj∕mol | 4 |
107 | lactiacidemia | 3 |
108 | leo/ml | 2 |
109 | leukopoiesis | 2 |
110 | local/vascular | 1 |
111 | low-density- | 1 |
112 | lrh-1 | 1 |
113 | mater-nal | 1 |
114 | methionol | 2 |
115 | mir-142-5p | 2 |
116 | mir-365 | 2 |
117 | mir-371-5p | 2 |
118 | morbi-mortality | 26 |
119 | morbidity | 17,685 |
120 | morbidity/mortality | 79 |
121 | morbility | 16 |
122 | morbimortality | 21 |
123 | mortality/morbidity | 27 |
124 | motorneurons | 2 |
125 | mv-uv | 2 |
126 | myonecrosis | 64 |
127 | nbt-reduction | 1 |
128 | neurosonography | 3 |
129 | obesity- | 5 |
130 | osteo-integration | 2 |
131 | other-derogation | 1 |
132 | p-xylylenediamine | 2 |
133 | p2- | 2 |
134 | pain-level | 1 |
135 | patch×time | 1 |
136 | paturition | 1 |
137 | pbsc- | 1 |
138 | perstans | 10 |
139 | pg-fluctuations | 1 |
140 | phospho-jnk1/2 | 1 |
141 | photophobia/phonophobia | 2 |
142 | photosynthesis- | 3 |
143 | piperidine-3,4-diol | 2 |
144 | pnpcdefg | 2 |
145 | potentiation- | 1 |
146 | predacity | 2 |
147 | pyruria | 1 |
148 | quimioprophylaxis | 1 |
149 | red-meat | 2 |
150 | reestenosis | 2 |
151 | renocortical | 1 |
152 | respiratory- | 2 |
153 | rfs/pfs | 1 |
154 | rosoxacin | 2 |
155 | rs10741657 | 3 |
156 | rs6773957 | 2 |
157 | securin | 2 |
158 | sexology | 3 |
159 | sights | 4 |
160 | snrnas | 4 |
161 | solace | 2 |
162 | ssti-related | 2 |
163 | staix-1 | 2 |
164 | stress-fetal | 1 |
165 | stroke/mi | 1 |
166 | t2- | 8 |
167 | tcf-1 | 3 |
168 | tetherin | 2 |
169 | tg/ldl | 2 |
170 | tooth-aches | 1 |
171 | total-igf-i | 1 |
172 | total-ldl | 1 |
173 | toxicodynamics | 5 |
174 | tramadol-sparing | 1 |
175 | uapo2 | 3 |
176 | underdiagnosing | 2 |
177 | underscreening | 2 |
178 | vasculo- | 3 |
179 | vasoplasm | 1 |
180 | venonemia | 2 |
181 | ventral/limbic | 1 |
182 | videostrobolaryngoscopy | 1 |
183 | visits/appointments | 1 |
184 | vlh | 1 |
185 | whvpg | 1 |
186 | wind-dampness | 3 |
187 | wind-dampness-dispelling | 2 |
188 | yi-qi-jian-pi | 2 |
189 | β-glucoronidase | 1 |
190 | δ-ala | 2 |
191 | δrk | 2 |
192 | ∼1.6- | 1 |
1 | 6.0- | 5 |
2 | 3.40- | 1 |
3 | il-1- | 1 |
4 | 1.82- | 1 |
5 | p2- | 2 |
6 | t2- | 8 |
7 | ∼1.6- | 1 |
8 | 1.86- | 4 |
9 | 1.3-2.7- | 1 |
10 | 37- | 1 |
11 | 1.97- | 1 |
12 | 2aa- | 1 |
13 | hypoxia- | 2 |
14 | apoa- | 3 |
15 | ampa- | 1 |
16 | pbsc- | 1 |
17 | idl- | 3 |
18 | cinobufacin- | 1 |
19 | potentiation- | 1 |
20 | contraction- | 1 |
21 | vasculo- | 3 |
22 | geno- | 3 |
23 | photosynthesis- | 3 |
24 | anti-rotavirus- | 1 |
25 | graft- | 2 |
26 | development- | 2 |
27 | respiratory- | 2 |
28 | obesity- | 5 |
29 | low-density- | 1 |
30 | hashsp70 | 2 |
31 | tcf-1 | 3 |
32 | lrh-1 | 1 |
33 | staix-1 | 2 |
34 | 18:1t-11 | 2 |
35 | bubr1 | 2 |
36 | phospho-jnk1/2 | 1 |
37 | uapo2 | 3 |
38 | mir-365 | 2 |
39 | rs10741657 | 3 |
40 | rs6773957 | 2 |
41 | brd7 | 3 |
42 | ag2s2o7 | 1 |
43 | 14:1c-9 | 1 |
44 | caspase‑9 | 4 |
45 | diseasea | 1 |
46 | photophobia/phonophobia | 2 |
47 | gynaecopathia | 1 |
48 | hyper-cholesterolaemia | 2 |
49 | lactiacidemia | 3 |
50 | digitalemia | 2 |
51 | venonemia | 2 |
52 | ketonemia | 4 |
53 | pyruria | 1 |
54 | hypogalactia | 2 |
55 | δ-ala | 2 |
56 | baro/volutrauma | 2 |
57 | ghrita | 3 |
58 | hirsuta | 3 |
59 | ventral/limbic | 1 |
60 | antiohyperglycemic | 1 |
61 | insulinomimetic | 2 |
62 | 1050°c | 2 |
63 | ssti-related | 2 |
64 | solace | 2 |
65 | g-tolerance | 1 |
66 | efflorescence | 2 |
67 | arterial-alveolar-difference | 1 |
68 | energy-intake | 1 |
69 | events-stroke | 1 |
70 | bradyasystole | 1 |
71 | patch×time | 1 |
72 | 3-methylcrotonylglycine | 3 |
73 | 3-methyhistidine | 1 |
74 | p-xylylenediamine | 2 |
75 | complications.deferoxamine | 1 |
76 | 1h-3-benzazonine | 1 |
77 | aminaftone | 2 |
78 | diarrhoe | 1 |
79 | hiv-exposure | 2 |
80 | β-glucoronidase | 1 |
81 | dose-per-pulse | 1 |
82 | bias/mse | 2 |
83 | fracture-rate | 1 |
84 | iso-valerate | 1 |
85 | pnpcdefg | 2 |
86 | 1.0-1.2mg/kg | 2 |
87 | crouching | 4 |
88 | wind-dampness-dispelling | 2 |
89 | underscreening | 2 |
90 | tramadol-sparing | 1 |
91 | underdiagnosing | 2 |
92 | whvpg | 1 |
93 | depression-research | 1 |
94 | vlh | 1 |
95 | total-igf-i | 1 |
96 | ciifn-i | 3 |
97 | stroke/mi | 1 |
98 | yi-qi-jian-pi | 2 |
99 | caapi | 4 |
100 | agresti | 3 |
101 | dyrk | 2 |
102 | δrk | 2 |
103 | renocortical | 1 |
104 | gonoccocal | 2 |
105 | hypodermal | 5 |
106 | mater-nal | 1 |
107 | stress-fetal | 1 |
108 | hormone-withdrawal | 1 |
109 | total-ldl | 1 |
110 | tg/ldl | 2 |
111 | pain-level | 1 |
112 | chamber-level | 2 |
113 | 60ng/ml | 3 |
114 | leo/ml | 2 |
115 | piperidine-3,4-diol | 2 |
116 | kj∕mol | 4 |
117 | methionol | 2 |
118 | hdl-cholersterol | 1 |
119 | vasoplasm | 1 |
120 | desulfomicrobium | 2 |
121 | epiclitum | 2 |
122 | haemogblobin | 1 |
123 | rosoxacin | 2 |
124 | tetherin | 2 |
125 | securin | 2 |
126 | other-derogation | 1 |
127 | osteo-integration | 2 |
128 | nbt-reduction | 1 |
129 | h₂o₂production | 1 |
130 | paturition | 1 |
131 | hypervolemia/hemodilution | 2 |
132 | mir-371-5p | 2 |
133 | mir-142-5p | 2 |
134 | amph-cpp | 2 |
135 | flna-g288r | 1 |
136 | local/vascular | 1 |
137 | complications.bladder | 1 |
138 | glt1-reporter | 1 |
139 | alcohol-hangover | 1 |
140 | firepower | 2 |
141 | snrnas | 4 |
142 | toxicodynamics | 5 |
143 | cspcs | 2 |
144 | ikds | 1 |
145 | tooth-aches | 1 |
146 | dumfries | 3 |
147 | diseases/injuries | 1 |
148 | alkylidenemalononitriles | 2 |
149 | event-rates | 2 |
150 | rfs/pfs | 1 |
151 | leukopoiesis | 2 |
152 | glycogenesis | 5 |
153 | reestenosis | 2 |
154 | myonecrosis | 64 |
155 | complications/sepsis | 1 |
156 | quimioprophylaxis | 1 |
157 | binols | 2 |
158 | caryophyllideans | 2 |
159 | perstans | 10 |
160 | coproporphyrins | 2 |
161 | pg-fluctuations | 1 |
162 | motorneurons | 2 |
163 | hysteroscops | 1 |
164 | creaminess | 3 |
165 | wind-dampness | 3 |
166 | sights | 4 |
167 | visits/appointments | 1 |
168 | e-apts | 2 |
169 | body-focus | 2 |
170 | red-meat | 2 |
171 | cost/punishment | 1 |
172 | mv-uv | 2 |
173 | bio-piracy | 2 |
174 | hypoparathyroidy | 1 |
175 | sexology | 3 |
176 | neurosonography | 3 |
177 | hole-only | 1 |
178 | videostrobolaryngoscopy | 1 |
179 | predacity | 2 |
180 | epileptogenicity | 2 |
181 | dendricity | 1 |
182 | chemotoxicity | 4 |
183 | morbidity | 17,685 |
184 | mortality/morbidity | 27 |
185 | morbi-mortality | 26 |
186 | morbidity/mortality | 79 |
187 | morbimortality | 21 |
188 | imageability | 3 |
189 | morbility | 16 |
190 | health/prematurity | 1 |
191 | cd68-immunoreactivity | 1 |
192 | interleukins-1α | 1 |